Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella ...
Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M
Repligen (RGEN), and 908 Devices (MASS) announced that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing ...
East Oregonian1d
Oregon UAS Accelerator honors past and future in remodel
The Oregon Unmanned Aerial Systems Accelerator facility is preparing to celebrate its newly renovated office, with a clear ...